New Psoriasis Drug

More information on PSORIASIS ...
What Are Some Promising Areas of Psoriasis Research?
Significant progress has been made in understanding the inheritance of psoriasis. A number of genes involved in psoriasis are already known or suspected. In a multifactor disease (involving genes, environment, and other factors), variations in one or more genes may produce a greater likelihood of getting the disease. Researchers are continuing to study the genetic aspects of psoriasis. Since discovering that inflammation in psoriasis is triggered by T cells, researchers have been studying new treatments that quiet immune system reactions in the skin. Among these are treatments that block the activity of T cells or block cytokines (proteins that promote inflammation). Several of these drugs are awaiting approval by the U.S. Food and Drug Administration (FDA).

Advances in laser technology are making it possible for doctors to experiment with laser light treatment of localized plaques. A UVB laser was recently tested in a study that was conducted at several medical centers. Although improvements in the skin were noted, this treatment is not without possible side effects. In some patients, the skin became inflamed, blistered, or discolored following treatment. - NIAMS

Top Resource Searches For:

New Psoriasis Drug

New Drug For Psoriasis
Breaking news on health topics for your family, finances, lifestyle, and business provided by applesforhealth.com, a healthy knowledge source. ... HospitalsChiropractorsEye DoctorsAlternate Health Prof.Drug InteractionsMedicationsDiseasesPoisonsInjuriesMental Health ... New Drug For Psoriasis. A new drug shows initial promise as a ...

Psoriasis drug gets new indication, warnings, dosing
HOME / TOP STORIES ARCHIVE / ARTICLE. TOP STORIES - ARTICLE. Psoriasis drug gets new indication, warnings, dosing. Acitretin has updated indication, more flexible dosing, but also new warning about depression, pregnancy.

National Psoriasis Foundation to Testify for Raptiva Approval
Password. News and Events. News. Federal Advisory Committee Recommends Approval of New Psoriasis Drug. Final approval could come by end of October. First posted Sept. 10, 2003. Last updated Sept. 23, 2003. In a unanimous vote on Sept. ... and Drug Administration (FDA) recommended approval of the psoriasis drug efalizumab (brand name Raptiva) for ...

HealthScout--New Psoriasis Drug Gains Approval
... Send to a Friend. New Psoriasis Drug Gains Approval ... A new drug to combat psoriasis has won approval from the U.S. Food and Drug Administration. ...

HON - News : Another New Drug for Psoriasis
... Another New Drug for Psoriasis. Efalizumb reduces reduces thick, red, scaly patches on skin ... "Biologics are a new approach to treating psoriasis. The symptom relief with biologics is ...

Genentech Says New Psoriasis Drug Batches Match Earlier Version
The biotech's study of a slightly different formula of Raptiva found no difference. ... Genentech Says New Psoriasis Drug Batches Match Earlier Version ... the FDA would complete a review of its new psoriasis drug, Amevive, within six months, slightly longer than many ...

MSNBC - FDA approves new psoriasis drug
... FDA approves new psoriasis drug. Raptiva should be available to consumers by Thanksgiving ... WASHINGTON - A new drug for the itchy-skin condition psoriasis won the Food and Drug ...

NBC 17 - Health Watch
The government wants to be ready if there's ever a massive flu outbreak -- but the biggest concern is the time it takes to make new vaccines. Full Story. In Depth: Flu Shots | Treatment. Are you ready to shed some pounds? ... Experts say a new blood pressure report shows Americans need to ... Illinois Drug Import Plan Concerns FDA ...

Psoriasis
... Lymphoma? - ABC News, 12/18/03. New Psoriasis Treatments Look Good - WebMD, 12/16/03 ... 11/10/03. New psoriasis drug wins FDA approval to use ...

Chronic Pain | New Psoriasis Drug